Palliative Intervention for Malignant Bowel Obstruction Comes at a Cost: A National Inpatient Study.

Autor:	Sun BJ; Surgical Oncology, Department of Surgery, Stanford University School of Medicine, Stanford, CA, USA., Tennakoon L; Department of Surgery, Stanford University School of Medicine, Stanford, CA, USA., Spain DA; Department of Surgery, Stanford University School of Medicine, Stanford, CA, USA., Lee B; Surgical Oncology, Department of Surgery, Stanford University School of Medicine, Stanford, CA, USA.
Jazyk:	angličtina
Zdroj:	The American surgeon [Am Surg] 2024 Nov; Vol. 90 (11), pp. 2848-2856. Date of Electronic Publication: 2024 May 23.
DOI:	10.1177/00031348241256083
Abstrakt:	Background: Malignant bowel obstruction (MBO) due to peritoneal carcinomatosis (PC) is associated with poor outcomes. Optimal management for palliation remains unclear. This study aims to characterize nonoperative, procedural, and operative management strategies for MBO and evaluate its association with mortality and cost. Materials and Methods: ICD-10 coding identified patient admissions from the 2018 to 2019 National Inpatient Sample (NIS) for MBO with PC from gastrointestinal or ovarian primary cancers. Management was categorized as nonoperative, procedural, or surgical. Multivariate analysis was used to associate treatment with mortality and cost. Results: 356,316 patient admissions were identified, with a mean age of 63 years. Gender, race, and insurance status were similar among groups. Length of stay (LOS) was longest in the surgical group (surgical: 17 days; procedural: 14 days; nonoperative: 7 days; P = .001). In comparison to nonoperative, procedural and surgical patients had statistically higher hospital charges, post-discharge medical needs, palliative care consults, and admission to rehab centers. Mortality was 7% in nonoperative, 9% in procedural, and 8% in surgical ( P = .007) groups. In adjusted analyses, older age, palliative care consult, and non-Medicare payer status were associated with higher mortality. Compared to nonoperative, procedural and surgical groups resulted in increased costs (procedural: $17K more; surgical: $30K more). Conclusions: Admissions for procedural and surgical treatment of MBO are associated with increased LOS, hospital costs, and discharge needs. Optimal management remains challenging. Clinicians must examine all options prior to recommending palliative interventions given a trend towards higher resource utilization and mortality. Competing Interests: Declaration of Conflicting InterestsThe author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu